Skip to main content

Peptidomimetics

  • Reference work entry
Drug Design

Abstract

Peptides are open-chain polymers made up of amino acids (Fig. 10.1). The main chain is made up of alternating amide groups ―CONH― and aliphatic carbon atoms, which are labeled C α . The side chains branch from the main chain at the C α atom. The amide group is barely flexible (Sect. 14.1). In contrast, a rotation around the C α –C β bond is possible. The side chains are flexible as well. Because of this, each amino acid can take on multiple conformations. As a consequence, peptides are very flexible molecules with many rotatable bonds and a multitude of possibilities to adopt different spatial configurations. Formally, there is no difference between the construction of peptides and proteins. Nonetheless, oligomers of amino acids up to a size of 30―50 monomer building blocks are called peptides, and the term protein is preferred for any members of this substance class that are above this limit.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 649.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 949.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

General Literature

  • Ahn J-M, Boyle NA, MacDonald MT, Janda KD (2002) Peptidomimetics and peptide backbone modifications. Mini Rev Med Chem 2:463–473

    Article  PubMed  CAS  Google Scholar 

  • Gante J (1994) Peptidomimetics—tailored enzyme inhibitors. Angew Chem Int Ed Engl 33:1699–1701

    Article  Google Scholar 

  • Giannis A, Kolter T (1993) Peptidomimetics for receptor ligands—discovery, development, and medical perspectives. Angew Chem Int Ed Engl 32:1244–1267

    Article  Google Scholar 

  • Hirschmann R (1991) Medicinal chemistry in the golden age of biology: lessons from steroid and peptide research. Angew Chem Int Ed Engl 30:1278–1301

    Article  Google Scholar 

  • Marahiel MA (2009) Working outside the protein-synthesis rules: Insights into non-ribosomal peptide synthesis. J Pept Sci 15:799–807

    Article  PubMed  CAS  Google Scholar 

Special Literature

  • Howson W (1995) Rational design of Tachykinin receptor antagonists. Drug News Perspect 8:97–103

    Google Scholar 

  • Lauri G, Bartlett PA (1994) CAVEAT: a program to facilitate the design of organic molecules. J Comput Aided Mol Des 8:51–66

    Article  PubMed  CAS  Google Scholar 

  • Lelais G, Seebach D (2004) β2-amino acids-synthesis, occurrence in natural products, and components of β-peptides. Biopolymers 76:206–243

    Article  PubMed  CAS  Google Scholar 

  • McLeod AM, Merchant KJ, Cascieri MA et al (1993) N-Acyl-Ltryptophan benzyl esters: potent substance P receptor antagonists. J Med Chem 36:2044–2045

    Article  Google Scholar 

  • Merchant KJ, Lewis RT, MacLeod AM (1994) Synthesis of homochiral ketones derived from L-tryptophan: potent substance P receptor antagonists. Tetrahedron Lett 35:4205–4208

    Article  CAS  Google Scholar 

  • Olson GL, Bolin DR, Bonner MP et al (1993) Concepts and progress in the development of peptide mimetics. J Med Chem 36:3039–3049

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Klebe, G. (2013). Peptidomimetics. In: Klebe, G. (eds) Drug Design. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-17907-5_10

Download citation

Publish with us

Policies and ethics